BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mooijaart SP, Du Puy RS, Stott DJ, Kearney PM, Rodondi N, Westendorp RGJ, den Elzen WPJ, Postmus I, Poortvliet RKE, van Heemst D, van Munster BC, Peeters RP, Ford I, Kean S, Messow CM, Blum MR, Collet TH, Watt T, Dekkers OM, Jukema JW, Smit JWA, Langhorne P, Gussekloo J. Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism. JAMA 2019;322:1977-86. [PMID: 31664429 DOI: 10.1001/jama.2019.17274] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 13.3] [Reference Citation Analysis]
Number Citing Articles
1 Lyko C, Blum MR, Abolhassani N, Stuber MJ, Del Giovane C, Feller M, Moutzouri E, Oberle J, Jungo KT, Collet TH, den Elzen WPJ, Poortvliet RKE, Du Puy RS, Dekkers OM, Trompet S, Jukema JW, Aujesky D, Quinn T, Westendorp R, Kearney PM, Gussekloo J, Van Heemst D, Mooijaart SP, Bauer DC, Rodondi N. Thyroid antibodies and levothyroxine effects in subclinical hypothyroidism: A pooled analysis of two randomized controlled trials. J Intern Med 2022. [PMID: 35894851 DOI: 10.1111/joim.13544] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Abbey EJ, McGready J, Oh E, Simonsick EM, Mammen JSR. Thyroid hormone use and overuse in dementia: Results from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2022. [PMID: 35866295 DOI: 10.1111/jgs.17961] [Reference Citation Analysis]
3 Zhao C, Wang Y, Xiao L, Li L. Effect of Levothyroxine on Older Patients With Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis. Front Endocrinol 2022;13:913749. [DOI: 10.3389/fendo.2022.913749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers 2022;8:30. [PMID: 35589725 DOI: 10.1038/s41572-022-00357-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Grani G. Levothyroxine Treatment of Subclinical Hypothyroidism in the Elderly Does Not Improve Hemoglobin Levels. Clinical Thyroidology 2022;34:199-201. [DOI: 10.1089/ct.2022;34.199-201] [Reference Citation Analysis]
6 Ma C, Zhong J, Zou Y, Liu Z, Li H, Pang J, Liu X, Zejipuchi, Tian L, Hou L, Wang D, Cheng X, Qiu L. Establishment of Reference Intervals for Thyroid-Associated Hormones Using refineR Algorithm in Chinese Population at High-Altitude Areas. Front Endocrinol 2022;13:816970. [DOI: 10.3389/fendo.2022.816970] [Reference Citation Analysis]
7 Biondi B, Cappola AR. Subclinical hypothyroidism in older individuals. The Lancet Diabetes & Endocrinology 2022;10:129-41. [DOI: 10.1016/s2213-8587(21)00285-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Ross DS. Treating hypothyroidism is not always easy: When to treat subclinical hypothyroidism, TSH goals in the elderly, and alternatives to levothyroxine monotherapy. J Intern Med 2021. [PMID: 34766382 DOI: 10.1111/joim.13410] [Reference Citation Analysis]
9 van Vliet NA, Bos MM, Thesing CS, Chaker L, Pietzner M, Houtman E, Neville MJ, Li-Gao R, Trompet S, Mustafa R, Ahmadizar F, Beekman M, Bot M, Budde K, Christodoulides C, Dehghan A, Delles C, Elliott P, Evangelou M, Gao H, Ghanbari M, van Herwaarden AE, Ikram MA, Jaeger M, Jukema JW, Karaman I, Karpe F, Kloppenburg M, Meessen JMTA, Meulenbelt I, Milaneschi Y, Mooijaart SP, Mook-Kanamori DO, Netea MG, Netea-Maier RT, Peeters RP, Penninx BWJH, Sattar N, Slagboom PE, Suchiman HED, Völzke H, Willems van Dijk K, Noordam R, van Heemst D; BBMRI Metabolomics Consortium. Higher thyrotropin leads to unfavorable lipid profile and somewhat higher cardiovascular disease risk: evidence from multi-cohort Mendelian randomization and metabolomic profiling. BMC Med 2021;19:266. [PMID: 34727949 DOI: 10.1186/s12916-021-02130-1] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 van Vliet NA, van Heemst D, Almeida OP, Åsvold BO, Aubert CE, Bae JB, Barnes LE, Bauer DC, Blauw GJ, Brayne C, Cappola AR, Ceresini G, Comijs HC, Dartigues JF, Degryse JM, Dullaart RPF, van Eersel MEA, den Elzen WPJ, Ferrucci L, Fink HA, Flicker L, Grabe HJ, Han JW, Helmer C, Huisman M, Ikram MA, Imaizumi M, de Jongh RT, Jukema JW, Kim KW, Kuller LH, Lopez OL, Mooijaart SP, Moon JH, Moutzouri E, Nauck M, Parle J, Peeters RP, Samuels MH, Schmidt CO, Schminke U, Slagboom PE, Stordal E, Vaes B, Völzke H, Westendorp RGJ, Yamada M, Yeap BB, Rodondi N, Gussekloo J, Trompet S; Thyroid Studies Collaboration. Association of Thyroid Dysfunction With Cognitive Function: An Individual Participant Data Analysis. JAMA Intern Med 2021;181:1440-50. [PMID: 34491268 DOI: 10.1001/jamainternmed.2021.5078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
11 Evron JM, Papaleontiou M. Decision Making in Subclinical Thyroid Disease. Med Clin North Am 2021;105:1033-45. [PMID: 34688413 DOI: 10.1016/j.mcna.2021.05.014] [Reference Citation Analysis]
12 Wiersinga WM. T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity. Endocrinol Metab (Seoul) 2021;36:938-51. [PMID: 34587734 DOI: 10.3803/EnM.2021.501] [Reference Citation Analysis]
13 Jonklaas J. Optimal Thyroid Hormone Replacement. Endocr Rev 2021:bnab031. [PMID: 34543420 DOI: 10.1210/endrev/bnab031] [Reference Citation Analysis]
14 Peng CC, Huang HK, Wu BB, Chang RH, Tu YK, Munir KM. Association of Thyroid Hormone Therapy with Mortality in Subclinical Hypothyroidism: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab 2021;106:292-303. [PMID: 33107557 DOI: 10.1210/clinem/dgaa777] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
15 Liew H, Watt T, Nan L, Tan AWK, Chan YH, Chew DEK, Dalan R. Psychometric properties of the thyroid-specific quality of life questionnaire ThyPRO in Singaporean patients with Graves' disease. J Patient Rep Outcomes 2021;5:54. [PMID: 34236563 DOI: 10.1186/s41687-021-00309-x] [Reference Citation Analysis]
16 Liu Y, Shan Z; Endocrine Metabolic Diseases Group of the Chinese Geriatrics Society., Thyroid Group of the Chinese Society of Endocrinology, Chinese Medical Association. Expert consensus on diagnosis and treatment for elderly with thyroid diseases in China (2021). Aging Med (Milton) 2021;4:70-92. [PMID: 34250426 DOI: 10.1002/agm2.12165] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Yoo WS, Chung HK. Subclinical Hypothyroidism: Prevalence, Health Impact, and Treatment Landscape. Endocrinol Metab (Seoul) 2021;36:500-13. [PMID: 34139799 DOI: 10.3803/EnM.2021.1066] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Zijlstra LE, Jukema JW, Westendorp RGJ, Du Puy RS, Poortvliet RKE, Kearney PM, O'Keeffe L, Dekkers OM, Blum MR, Rodondi N, Collet TH, Quinn TJ, Sattar N, Stott DJ, Trompet S, den Elzen WPJ, Gussekloo J, Mooijaart SP. Levothyroxine Treatment and Cardiovascular Outcomes in Older People With Subclinical Hypothyroidism: Pooled Individual Results of Two Randomised Controlled Trials. Front Endocrinol (Lausanne) 2021;12:674841. [PMID: 34093444 DOI: 10.3389/fendo.2021.674841] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
19 Borson-Chazot F, Terra JL, Goichot B, Caron P. What Is the Quality of Life in Patients Treated with Levothyroxine for Hypothyroidism and How Are We Measuring It? A Critical, Narrative Review. J Clin Med 2021;10:1386. [PMID: 33808358 DOI: 10.3390/jcm10071386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Nordqvist SF, Boesen VB, Rasmussen ÅK, Feldt-Rasmussen U, Hegedüs L, Bonnema SJ, Cramon PK, Watt T, Groenvold M, Bjorner JB. Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO. Endocr Connect 2021;10:316-24. [PMID: 33617467 DOI: 10.1530/EC-21-0026] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
21 van der Spoel E, Roelfsema F, van Heemst D. Within-Person Variation in Serum Thyrotropin Concentrations: Main Sources, Potential Underlying Biological Mechanisms, and Clinical Implications. Front Endocrinol (Lausanne) 2021;12:619568. [PMID: 33716972 DOI: 10.3389/fendo.2021.619568] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
22 Burgos N, Toloza FJK, Singh Ospina NM, Brito JP, Salloum RG, Hassett LC, Maraka S. Clinical Outcomes After Discontinuation of Thyroid Hormone Replacement: A Systematic Review and Meta-Analysis. Thyroid 2021;31:740-51. [PMID: 33161885 DOI: 10.1089/thy.2020.0679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
23 Modarressi T. Challenges in Defining and Studying Subclinical Hypothyroidism in Older Adults. Am J Med 2021;134:e70. [PMID: 33342474 DOI: 10.1016/j.amjmed.2020.08.024] [Reference Citation Analysis]
24 Stojković M, Žarković M. Subclinical Thyroid Dysfunction and the Risk of Cardiovascular Disease. Curr Pharm Des 2020;26:5617-27. [PMID: 33213317 DOI: 10.2174/1381612826666201118094747] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Du Puy RS, Poortvliet RKE, Mooijaart SP, den Elzen WPJ, Jagger C, Pearce SHS, Arai Y, Hirose N, Teh R, Menzies O, Rolleston A, Kerse N, Gussekloo J. Outcomes of Thyroid Dysfunction in People Aged Eighty Years and Older: An Individual Patient Data Meta-Analysis of Four Prospective Studies (Towards Understanding Longitudinal International Older People Studies Consortium). Thyroid 2021;31:552-62. [PMID: 33012278 DOI: 10.1089/thy.2020.0567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
26 Schlögl M, Riese F, Little MO, Blum D, Jox RJ, O'Neill L, Pautex S, Piers R, Way D, Jones CA. Top Ten Tips Palliative Care Clinicians Should Know About Cognitive Impairment and Institutional Care. J Palliat Med 2020;23:1525-31. [PMID: 32955961 DOI: 10.1089/jpm.2020.0552] [Reference Citation Analysis]
27 Razvi S, Arnott B, Teare D, Hiu S, O'Brien N, Pearce SH. Multinational Survey of Treatment Practices of Clinicians Managing Subclinical Hypothyroidism in Older People in 2019. Eur Thyroid J 2021;10:330-8. [PMID: 34395305 DOI: 10.1159/000509228] [Reference Citation Analysis]
28 Choi BW, Kim S, Kang S, Won KS, Yi HA, Kim HW. Relationship Between Thyroid Hormone Levels and the Pathology of Alzheimer's Disease in Euthyroid Subjects. Thyroid 2020;30:1547-55. [PMID: 32438896 DOI: 10.1089/thy.2019.0727] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Goichot B, Raverot V, Klein M, Vija Racaru L, Abeillon-du Payrat J, Lairez O, Leroy R, Cailleux A, Wolff P, Groussin L, Kaltenbach G, Caron P. Management of thyroid dysfunctions in the elderly. French Endocrine Society consensus 2019 guidelines. Short version. Ann Endocrinol (Paris) 2020;81:511-5. [PMID: 32446837 DOI: 10.1016/j.ando.2020.05.002] [Reference Citation Analysis]
30 Goichot B, Raverot V, Klein M, Vija Racaru L, Abeillon-Du Payrat J, Lairez O, Leroy R, Cailleux A, Wolff P, Groussin L, Kaltenbach G, Caron P. Management of thyroid dysfunctions in the elderly. French Endocrine Society consensus statement 2019. Long version. Ann Endocrinol (Paris) 2020;81:89-100. [PMID: 32416938 DOI: 10.1016/j.ando.2020.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Chrysant SG. The current debate over treatment of subclinical hypothyroidism to prevent cardiovascular complications. Int J Clin Pract 2020;74:e13499. [PMID: 32159256 DOI: 10.1111/ijcp.13499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]